טוען...
The TLR4 agonist monophosphoryl lipid A drives broad resistance to infection via dynamic reprogramming of macrophage metabolism
Monophosphoryl lipid A (MPLA) is a clinically utilized toll-like receptor (TLR) 4 agonist that has been found to drive non-specific resistance to infection for up to two weeks. However, the molecular mechanisms conferring protection are not well understood. Here, we found that MPLA prompts resistanc...
שמור ב:
| הוצא לאור ב: | J Immunol |
|---|---|
| Main Authors: | , , , , , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5964009/ https://ncbi.nlm.nih.gov/pubmed/29686054 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4049/jimmunol.1800085 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|